LISA STATZ: Open Payments
NPI 1629511175 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 118 payments from 16 companies in 2025. Trend: 2023 $1,673 · 2024 $1,914 · 2025 $2,274
Food & beverage: $2,085Education: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $696 |
| Janssen Biotech, Inc. | 18 | $468 |
| Novartis Pharmaceuticals Corporation | 18 | $385 |
| Regeneron Healthcare Solutions, Inc. | 12 | $257 |
| Organon LLC | 6 | $97 |
| UCB, Inc. | 4 | $84 |
| GENZYME CORPORATION | 2 | $61 |
| Lilly USA, LLC | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Amgen Inc. | 1 | $31 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, COSENTYX, Rhapsido, RINVOQ, Bimzelx, TALTZ.
Industry payments across MA — which companies pay providers there.
